Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Half year trading update

3 Aug 2015 07:00

RNS Number : 8042U
Toumaz Limited
03 August 2015
 



3 August 2015

 

Toumaz Limited

 

Half year trading update

 

Toumaz Limited (AIM: TMZ, 'Toumaz', or the 'Group'), a pioneer in low-power, wireless semiconductor technologies for digital audio and healthcare, provides the following trading update for the six months ended 30 June 2015. 

 

Financial highlights

 

· Revenues up 30% at £14.0m (H1 2014: £10.8m)

· Gross profit up 40% to £6.3m (H1 2014: £4.5m)

· EBITDA loss £5.5m (H1 2014: loss £5.6m)

· R&D expenditure: £6.4m (H1 2014: £5.1m)

· As at 30 June 2015, the cash balance was £5.5m (31 December 2015: £12.5 million)

 

Overview

 

The Digital Audio division has performed strongly with revenues up 34% at £13.8m (£10.3m in H1 2014). Growth has been driven by the international expansion of digital radio and the rapid emergence of the connected audio market. Toumaz is well-positioned in both sectors and the recent co-development agreement with Google is a strong endorsement of the Group's forthcoming next generation connected audio solution.

 

In Healthcare, the commercial delivery of SensiumVitals® remains slow with revenues of £0.2m (£0.5m in H1 2014); but based on recent trials the Board remains confident that the fundamental economic and clinical value of the system will be demonstrated.

 

Anthony Sethill, CEO of Toumaz, commented:

 

"We are delighted with the growth of our Digital Audio business. Our co-development agreement with Google will be an important factor in further developing our position in connected audio.

 

"We are trialling SensiumVitals® in a number of hospitals, including the Queen Elizabeth Hospital Birmingham and St James's Hospital, Leeds. However, these complex systems for the healthcare environment need considerable amounts of data and trialling, which have delayed our commercial roll out.

 

"Overall, given the strong performance by Digital Audio, we remain on course to continue to grow the business in the second half of the year."

 

Enquiries:

 

Toumaz Limited

+44 (0)20 7391 0630

Anthony Sethill, Chief Executive Officer

Jonathan Apps, Chief Financial Officer

Peel Hunt LLP (Nominated Adviser and Broker)

+44 (0)20 7418 8900

Richard Kauffer/Euan Brown

Instinctif Partners

+44 (0)20 7457 2020

Adrian Duffield/Chantal Woolcock

 

About Toumaz (www.toumaz.com)

 

Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and digital audio. The company has two divisions, Sensium Healthcare and Frontier Silicon. Sensium Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chips, modules and software for digital radio and connected audio devices.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFSRDAILVIE
Date   Source Headline
14th Jun 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
6th Jun 20195:43 pmRNSHolding(s) in Company
6th Jun 20193:30 pmRNSInvestment in Frontier Smart Technologies Grp Ltd
30th May 20197:00 amRNSFormal Chairman Appointment
29th May 20191:02 pmRNSHolding(s) in Company
29th May 20197:00 amRNSHolding(s) in Company
21st May 20197:00 amRNSHolding(s) in Company
20th May 20199:00 amRNSPrice Monitoring Extension
20th May 20197:00 amRNSTermination of Discussions and Holding in Company
17th May 201912:01 pmRNSHolding(s) in Company
14th May 201912:07 pmRNSResult of Annual General Meeting
9th May 20194:40 pmRNSSecond Price Monitoring Extn
9th May 20194:35 pmRNSPrice Monitoring Extension
9th May 20197:00 amRNSTrading Update
1st Apr 20194:40 pmRNSSecond Price Monitoring Extn
1st Apr 20194:35 pmRNSPrice Monitoring Extension
20th Mar 20197:00 amRNSFinal Results
7th Mar 20197:00 amRNSBlock listing Interim Review
6th Mar 20197:00 amRNSNotice of Results
28th Feb 20197:00 amRNSFrontier extends focus into Smart Home IoT
17th Jan 20197:00 amRNSTrading Update and Notice of Results
11th Jan 201911:36 amRNSNotification of Major Holdings
30th Nov 20185:19 pmRNSNotification of major holdings
15th Nov 20187:00 amRNSTotal Voting Rights
28th Sep 20183:36 pmRNSBlock Listing Update
18th Sep 20187:00 amRNSHalf-Year Results
16th Aug 20187:00 amRNSTotal Voting Rights
13th Aug 20187:00 amRNSNotice of Results
26th Jul 20187:00 amRNSTrading Update
16th Jul 20187:00 amRNSTotal Voting Rights
9th Jul 20187:00 amRNSBoard Appointment
12th Jun 20184:27 pmRNSTotal Voting Rights
23rd May 201811:05 amRNSSecond Price Monitoring Extn
23rd May 201811:00 amRNSPrice Monitoring Extension
23rd May 20187:00 amRNSTrading Update
8th May 20185:49 pmRNSTotal Voting Rights
24th Apr 201811:58 amRNSResult of Annual General Meeting
29th Mar 20187:00 amRNSBlock Listing Update and TVR
19th Mar 20184:10 pmRNSPosting of Annual Report and Notice of AGM
8th Mar 20187:00 amRNSBoard Changes
8th Mar 20187:00 amRNSFinal Results
20th Feb 20187:00 amRNSNotice of Results
5th Feb 20182:21 pmRNSNotification of major holdings
25th Jan 20187:00 amRNSTrading Update
2nd Jan 20187:00 amRNSNotification of Major Holdings
29th Nov 201712:40 pmRNSDirector/PDMR Shareholding
29th Nov 201712:40 pmRNSTotal Voting Rights
13th Nov 20177:00 amRNSSmart Audio technology contract win
6th Oct 201712:58 pmRNSTotal Voting Rights
28th Sep 20177:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.